Your browser doesn't support javascript.
loading
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study.
Kelly, William K; Danila, Daniel C; Lin, Chia-Chi; Lee, Jae-Lyun; Matsubara, Nobuaki; Ward, Patrick J; Armstrong, Andrew J; Pook, David; Kim, Miso; Dorff, Tanya B; Fischer, Stefanie; Lin, Yung-Chang; Horvath, Lisa G; Sumey, Christopher; Yang, Zhao; Jurida, Gabor; Smith, Kristen M; Connarn, Jamie N; Penny, Hweixian L; Stieglmaier, Julia; Appleman, Leonard J.
Afiliação
  • Kelly WK; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Danila DC; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Lin CC; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lee JL; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Matsubara N; National Taiwan University Hospital, Taipei, Taiwan.
  • Ward PJ; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Armstrong AJ; National Cancer Center Hospital East, Chiba, Japan.
  • Pook D; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Kim M; Oncology Hematology Care, Cincinnati, Ohio.
  • Dorff TB; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Fischer S; Monash Health, Clayton, Victoria, Australia.
  • Lin YC; Seoul National University Hospital, Seoul, South Korea.
  • Horvath LG; City of Hope, Duarte, California.
  • Sumey C; Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Yang Z; Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Jurida G; Chris O'Brien Lifehouse, University of Sydney, Sydney, New South Wales, Australia.
  • Smith KM; Sanford Cancer Center, Sioux Falls, South Dakota.
  • Connarn JN; Amgen Inc., Thousand Oaks, California.
  • Penny HL; Amgen Inc., Thousand Oaks, California.
  • Stieglmaier J; Amgen Inc., South San Francisco, California.
  • Appleman LJ; Amgen Inc., South San Francisco, California.
Cancer Discov ; 14(1): 76-89, 2024 01 12.
Article em En | MEDLINE | ID: mdl-37861461
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article